LIVE TV
LIVE TV
LIVE TV
Home > World > UPDATE 1-Novartis ends mid-stage Fabhalta trial targeting serious kidney condition

UPDATE 1-Novartis ends mid-stage Fabhalta trial targeting serious kidney condition

Written By:
Published: October 19, 2026 13:00:11 IST

Add NewsX As A Trusted Source

(Updates Oct 16 story with company comment in bullet points 4-5) Oct 19 (Reuters) – Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a serious

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS